S Jamal Mustafa Selected Research

Respiratory Hypersensitivity

7/2010	Involvement of A1 adenosine receptors in altered vascular responses and inflammation in an allergic mouse model of asthma.
4/2005	Involvement of mast cells in adenosine-mediated bronchoconstriction and inflammation in an allergic mouse model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S Jamal Mustafa Research Topics

Disease

12	Inflammation (Inflammations) 01/2020 - 01/2002
10	Asthma (Bronchial Asthma) 01/2020 - 01/2002
5	Atherosclerosis 01/2021 - 07/2011
5	Ischemia 08/2011 - 09/2002
4	Hypertension (High Blood Pressure) 01/2021 - 02/2018
4	Hyperemia 01/2021 - 05/2013
3	Pneumonia (Pneumonitis) 01/2020 - 01/2002
3	Hypoxia (Hypoxemia) 08/2013 - 01/2009
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2019
2	Myocardial Infarction 01/2019 - 12/2017
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2016 - 07/2011
2	Body Weight (Weight, Body) 04/2014 - 08/2003
2	Respiratory Hypersensitivity 07/2010 - 04/2005
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021
1	Vascular System Injuries 01/2020
1	Vascular Ring 02/2018
1	Myocarditis (Carditis) 01/2017
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2016
1	Reperfusion Injury 08/2013
1	Endotoxemia 07/2013
1	Hyperlipidemias (Hyperlipidemia) 07/2011
1	Airway Obstruction (Choking) 01/2009
1	Chest Pain (Chest Pains) 11/2004
1	Ataxia (Dyssynergia) 12/2002

Drug/Important Bio-Agent (IBA)

24	Adenosine (Adenocard)FDA LinkGeneric 01/2021 - 01/2002
14	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2020 - 01/2002
5	Adenosine Triphosphate (ATP)IBA 01/2020 - 03/2003
5	AllergensIBA 07/2010 - 01/2002
4	Adenosine-5'-(N-ethylcarboxamide) (NECA)IBA 01/2020 - 04/2005
4	KATP ChannelsIBA 10/2014 - 09/2002
3	AerosolsIBA 01/2020 - 05/2008
2	uridine adenosine tetraphosphateIBA 01/2019 - 12/2017
2	Apolipoproteins E (ApoE)IBA 12/2017 - 04/2014
2	regadenoson FDA Link 01/2016 - 07/2011
2	Purinergic P1 Receptor AntagonistsIBA 03/2007 - 10/2005
2	Histamine (Histamine Dihydrochloride)FDA Link 12/2006 - 10/2005
2	Ethanol (Ethyl Alcohol)IBA 08/2003 - 12/2002
1	ectoATPaseIBA 01/2020
1	OvalbuminIBA 01/2020
1	Terpenes (Terpenoids)IBA 01/2020
1	Methacholine Chloride (Methacholine)FDA Link 01/2020
1	LimoneneIBA 01/2020
1	EnzymesIBA 01/2020
1	PD 123319IBA 06/2019
1	Arg-Pro-Leu-Lys-Pro-TrpIBA 06/2019
1	Losartan (Cozaar)FDA LinkGeneric 06/2019
1	Angiotensin IIIBA 06/2019
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 02/2018
1	Apelin ReceptorsIBA 01/2017
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2017
1	2- (4- (2- carboxyethyl)phenethylamino)- 5'- N- ethylcarboxamidoadenosineIBA 01/2016
1	LipopolysaccharidesIBA 07/2013
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 05/2013
1	CytokinesIBA 05/2008
1	3- ethyl- 1- propyl- 8- (1- (3- trifluoromethylbenzyl)- 1H- pyrazol- 4- yl)- 3,7- dihydropurine- 2,6- dioneIBA 03/2007
1	Adenosine Monophosphate (AMP)IBA 03/2007
1	Adenosine A1 ReceptorIBA 12/2006
1	montelukast (Singulair)FDA Link 12/2006
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2006
1	Messenger RNA (mRNA)IBA 10/2006
1	purineIBA 10/2005
1	p-Methoxy-N-methylphenethylamineIBA 04/2005
1	N(6)-(2-endo-norbornyl)adenosineIBA 03/2003
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 03/2003
1	Dronabinol (THC)FDA LinkGeneric 12/2002
1	Psychotropic Drugs (Psychoactive Drugs)IBA 12/2002
1	OligodeoxyribonucleotidesIBA 12/2002
1	CannabinoidsIBA 12/2002
1	Glyburide (Glibenclamide)FDA LinkGeneric 09/2002
1	1,3-dipropyl-8-cyclopentylxanthineIBA 09/2002
1	chelerythrineIBA 09/2002
1	S-methylisothiopseudouroniumIBA 09/2002
1	Theophylline (Theon)FDA LinkGeneric 01/2002

Therapy/Procedure

1	Baths 02/2018
1	Therapeutics 10/2005